Quale sarebbe il prezzo per Jiangsu Recbio Technology Co., Ltd. (2179)

Il prezzo per Jiangsu Recbio Technology Co., Ltd. (2179) è $0.63963115

Qual è la capitalizzazione di mercato per Jiangsu Recbio Technology Co., Ltd. (2179)

La capitalizzazione di mercato per Jiangsu Recbio Technology Co., Ltd. (2179) è $339.16M

Jiangsu Recbio Technology Co., Ltd. (2179) Prezzo e Capitalizzazione di Mercato

Jiangsu Recbio Technology Co., Ltd. operates as a biotechnology company primarily engaged in the pioneering research, development, and eventual market introduction of subunit vaccines throughout the People's Republic of China. A significant portion of its pipeline is dedicated to combating human papillomavirus (HPV)-related diseases, including cervical cancer and genital warts. Its most advanced candidate, REC603, is a recombinant 9-valent HPV vaccine currently undergoing Phase III clinical trials. Additionally, two bivalent HPV vaccines, REC601 and REC602, are progressing through Phase I trials. Further early-stage development includes the quadrivalent REC604a and 9-valent REC604b recombinant HPV vaccines, both in preclinical stages. Beyond HPV, the company boasts a diverse pipeline addressing other infectious diseases. Its COVID-19 efforts include ReCOV, a recombinant vaccine candidate in Phase II/III trials, and the preclinical messenger RNA (mRNA) candidate, R520A. Other preclinical projects target various conditions, such as the recombinant shingles vaccine REC610, the virus-vectored adult tuberculosis vaccine REC607, and its recombinant counterpart REC606. Also in preclinical development are the recombinant quadrivalent influenza vaccine REC617 and the recombinant quadrivalent hand-foot-mouth disease vaccine REC605. Established in 2011, Recbio Technology maintains its headquarters in Taizhou, People's Republic of China.

Il prezzo per 2179	Attivo B	Capitalizzazione del mercato a B	Risultati
$10,015.91 $339.16M	NVDA	$5.311T	+1,565,789.11%
$9,005.48 $339.16M	AAPL	$4.775T	+1,407,816.91%
$7,605.85 $339.16M	GOOG	$4.033T	+1,188,999.71%
$7,012.93 $339.16M	MSFT	$3.719T	+1,096,301.59%
$5,175.78 $339.16M	AMZN	$2.744T	+809,082.46%

Il prezzo per 2179

Attivo B

Capitalizzazione del mercato a B

Risultati

$10,015.91 $339.16M